THE TESTIMONIALS OF OUR CUSTOMERS TESTIFY OF IDDI’S ADDED VALUE OF A HIGHLY SKILLED SERVICES OFFERING FOR CLINICAL RESEARCH.
Valuable consultancy services
VelosBio worked closely with Marc Buyse and Elisabeth Coart. They were both very insightful, knowledgeable, innovative in their approach, communicative, and rapidly responsive with their development and review of documents. The support they provided was very valuable and our interactions with them were truly a pleasure. I would be more than happy to recommend IDDI to others. Langdon L Miller, MD, Executive Vice President of Development/Chief Medical Officer, VelosBio Inc.
Reached internal consensus quickly
In my opinion Katrien (at IDDI) is terrific and has done a wonderful job for us. We mostly avoided and substantive statistical discussion with FDA and reached internal consensus about the approach very quickly. Having said that, Katrien contributed significantly and productively to our pre-meeting discussions and truly helped us shape our thinking. Michael H. Silverman, MD, FACP, President of BioStrategics Consulting Ltd
System build timelines are the fastest of any vendor
I only have good things to say about IDDI: consistently responsive and prompt with communications, displays regular flexibility in meeting Pharmasset needs and changing study designs, exhibit professional and respectful attitude, HelpDesk support regularly provides fast resolution and response for CRO, Site and Pharmasset staff, knowledgeable and understanding of not only EDC, IWRS platforms, but the clinical trial process and how to best (proactively and reactively) implement design strategies, system build timelines are the fastest of any vendor I have seen, little or no go-live issues arise. Implementation of system changes (ID-net or Marvin) in live environment occur seamlessly and without any noticeable system downtime. Michael Mader, Director Clinical Operations, Pharmasset, Princeton, NJ, USA
Switching from paper CRFs to EDC
Switching from paper CRFs to EDC not only significantly reduced the time taken to issue and respond to queries, it also allowed us to lock our database 2 weeks after the last patient visit. This would not have been possible with paper CRFs. IDDI made process of switching from paper to electronic CRFs mid-study easy for us and easy for our sites. Desiree Beutelspacher, Director, Clinical Development, Ophthotech, New York, USA
EDC system goes live in a short amount of time
Thank you for your hard work and diligence in getting this EDC system up in an extremely short amount of time! I have not experienced a vendor in the past who can go from eCRF/User Requirements approved to system live in a timeframe like this! You deserve a huge round of applause!!
Rose Johnstone, Clinical Data Management Director, Pharmasset, Princeton, NJ, USA
IDDI shows commitment to quality and precision
We are truly grateful to all those who participated in this important study. Our partnership with IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
Outstanding statistical work
IDDI performed an excellent job on the data management, IWRS and EDC functions for our large phase 2 study, and the statistical work was outstanding. The statistical group was extremely responsive and flexible, and despite the time difference between the U.S and Belgium the process was seamless and the response was extremely fast, even when the workload was very demanding. The output from the statistical group was meticulous and precise during a period of very ambitious time lines. Dr. Samir Patel, President and CEO, Ophthotech, Princeton, NJ, USA
EDC go-live: A superb effort indeed to get this done in short timelines!
Thank you for being flexible in the way you have been, this has given us a great result so we are ready to start the study!
Zubair Hussain VP Regulatory & Clinical Affairs, iSTAR Medical
Flexibility to IDMC Request
IDDI staff was quite flexible to IDMC requests. They were adept at pointing out risks that AZ had inadvertently overlooked, and would always offer solutions to mitigate the risks. The planning and actual meeting with the IDMC was hitch-free. IDDI staff was always very professional, and I would rate them 5 on a scale of 1 – 5. My interaction with IDDI staff have been through e-mails and teleconferences. They were prompt in calling into meetings, and responding to e-mails. Ugochi A Emeribe, Principal Statistician, Astrazeneca R&D, Wilmington, DE, USA